Martin Fan
Stock Analyst at Wedbush
(4.83)
# 73
Out of 5,090 analysts
15
Total ratings
78.57%
Success rate
55.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Assumes: Neutral | $9 | $8.17 | +10.16% | 1 | Nov 25, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $6.46 | -69.04% | 1 | Nov 25, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $50 | $44.29 | +12.91% | 4 | Nov 24, 2025 | |
| SANA Sana Biotechnology | Maintains: Outperform | $5 → $6 | $5.14 | +16.73% | 2 | Nov 7, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Outperform | $18 → $23 | $3.37 | +582.49% | 2 | Oct 17, 2025 | |
| ZBIO Zenas BioPharma | Maintains: Outperform | $35 → $40 | $39.36 | +1.63% | 2 | Oct 9, 2025 | |
| RNAC Cartesian Therapeutics | Initiates: Outperform | $38 | $6.90 | +450.72% | 1 | Jul 9, 2025 | |
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $2.93 | +173.50% | 1 | May 28, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Outperform | $40 | $30.66 | +30.46% | 1 | May 15, 2025 |
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $8.17
Upside: +10.16%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.46
Upside: -69.04%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $44.29
Upside: +12.91%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5 → $6
Current: $5.14
Upside: +16.73%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $3.37
Upside: +582.49%
Zenas BioPharma
Oct 9, 2025
Maintains: Outperform
Price Target: $35 → $40
Current: $39.36
Upside: +1.63%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $6.90
Upside: +450.72%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $2.93
Upside: +173.50%
Oruka Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $40
Current: $30.66
Upside: +30.46%